Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Macaulay Capital Plc M&A Activity 2026

Mar 9, 2026

6067_rns_2026-03-09_3b5598d1-ec48-42e5-8506-f18da8d427a0.html

M&A Activity

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 8359V

Macaulay Capital PLC

09 March 2026

9 March 2026

Macaulay Capital PLC

("Macaulay" or the "Company")

Completion of disposal of ICA Limited ("ICA") and receipt of performance fees

Macaulay Capital PLC (AQSE:MCAP), which was formed to originate and manage corporate transactions, raise funds from third parties, invest its own funds alongside those of external investors and to manage its investment portfolio with the aim of maximising its value, announces the completion of the sale by related investors of their interests in ICA, a portfolio company, and associated fees payable to Macaulay.

As announced on 11 February 2026, a newly formed bidco, Certania Acquico-UK Ltd, established by Certania Holding GmbH, conditionally agreed to acquire ICA ("the Disposal").  All the conditions have now been satisfied and as announced on 6 March 2026 by CEPS plc, which owned shares in ICA, the Disposal has completed.

For investors introduced by Chelverton Asset Management Limited, the consideration represents a return of up to 15.5 times their original investment in 2016, pre-performance fees.

Also and as a result of the return on the investment, management and performance fees are payable by certain ICA shareholders to Macaulay of £349,508. 

ENDS 

Enquiries:

Macaulay Capital PLC
Clive Milner +44 (0)20 3946 5980
Cairn Financial Advisers LLP (AQSE Corporate Adviser)
Louise O'Driscoll +44 (0)20 7213 0880
Oberon Capital (Broker)
Chris Crawford +44 (0)20 3179 5304

For more information please visit: www.macaulaycapital.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXSSSESAEMSESD